NCT01834131

Brief Summary

The objective of this cluster randomized trial is to test whether a comprehensive intervention program within a national public primary care system will improve hypertension control among uninsured hypertensive patients and their families in Argentina.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,954

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Jun 2013

Typical duration for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 17, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

July 17, 2017

Status Verified

July 1, 2017

Enrollment Period

3.3 years

First QC Date

April 13, 2013

Last Update Submit

July 12, 2017

Conditions

Keywords

hypertensioncommunity health workerhome health educationmedication adherencemobile healthphysician educationhome blood pressure monitoringimplementation

Outcome Measures

Primary Outcomes (1)

  • Net change in systolic (SBP) and diastolic BP (DBP) from baseline to month 18 between the intervention and control groups among hypertensive study participants.

    Three BP measurements will be obtained at each data collection visit by study nurses who are masked to clinic assignment. BP will be measured according to a standard protocol recommended by the American Heart Association. The average of the three measurements will be used to compare the change over 18 months between the intervention and control groups.

    Baseline and 18 months

Secondary Outcomes (6)

  • Proportion of hypertension control (BP<140/90 mmHg) among hypertensive patients

    Baseline and 18 months

  • Self-reported medication adherence among hypertensive patients

    Baseline and 18 months

  • Cost-effectiveness of the intervention

    Baseline and 18 Months

  • Net change in systolic (SBP) and diastolic BP (DBP) from baseline to month 18 between the intervention and control groups among normotensive study participants

    Baseline and 18 months

  • Net change in body weight and waist circumference from baseline to 18 months

    Baseline and 18 months

  • +1 more secondary outcomes

Study Arms (2)

Usual Care

NO INTERVENTION

Clinics assigned to usual care will not receive any of the intervention components. Physicians in these clinics will continue to treat patients using their usual methods. Participants from these clinics will not receive community health worker visits or the mobile health intervention

Comprehensive Intervention

EXPERIMENTAL

1. Physicians will receive training in the use of treatment algorithms based on hypertension guidelines. 2. Community health workers (CHW) will be trained in facilitating behavioral change through BP monitoring, medication management, and lifestyle modifications. CHW will serve as a source of education, motivation, and social support, and as facilitators of healthcare utilization for participants. CHW will conduct home visits, schedule appointments with primary care physicians, deliver antihypertensive medications to patients' homes, and provide tailored counseling to address barriers to behavior change. 3. Individualized text messages to promote lifestyle changes and reminders to reinforce medication adherence will be sent to participants weekly.

Behavioral: Comprehensive Intervention

Interventions

The comprehensive intervention includes physician education, a community health worker home intervention and a mobile health intervention. Please see Arm Description for details.

Comprehensive Intervention

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The clinic is affiliated with the Remediar+Redes program.
  • The clinic is located in urban poor areas according to the 2010 census data.
  • The clinic has ≥1000 outpatient visits each month, so that sufficient participants can be recruited.
  • The minimum distance between the selected clinics will be 10 kilometers to minimize the risk for contamination of the intervention.
  • Physician visits and essential medications are free of charge to patients under all circumstances.
  • The clinic has a high number of prescriptions for antihypertensive medications.
  • The clinic employs community health workers.
  • The clinic has general practitioners and nurses.
  • The clinic has a history of good performance in the Remediar+Redes program.
  • The clinic performs blood draws on patients when appropriate.
  • Patients aged ≥21 years who received primary care from the participating clinics and have hypertension ( SBP ≥140 mmHg and/or DBP ≥90 mmHg on at least 2 separate visits) and their spouses (with or without hypertension) and/or any adult hypertensive family members (age ≥21 years) living in the same household will be included.
  • Hypertension patients and their spouses and/or family members must be available for the first baseline nurse home visit.
  • The index patient must have a cell phone that receives text messages.
  • The family's homes must be located within 10 kilometers from the clinic.

You may not qualify if:

  • Hypertension patients who do not have a spouse or another adult with hypertension in the household.
  • Plans to move from the neighborhood in the next two years
  • Pregnant women or women who are planning to become pregnant in the next two years
  • Persons who are bed-bound
  • Persons who cannot give informed consent
  • Persons with an arm circumference \>50 cm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Clinical Effectiveness and Health Policy

Buenos Aires, C1414CPV, Argentina

Location

Related Publications (5)

  • Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912.

    PMID: 27502908BACKGROUND
  • Mills KT, Rubinstein A, Irazola V, Chen J, Beratarrechea A, Poggio R, Dolan J, Augustovski F, Shi L, Krousel-Wood M, Bazzano LA, He J. Comprehensive approach for hypertension control in low-income populations: rationale and study design for the hypertension control program in Argentina. Am J Med Sci. 2014 Aug;348(2):139-45. doi: 10.1097/MAJ.0000000000000298.

  • Palmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012675. doi: 10.1002/14651858.CD012675.pub3.

  • Poggio R, Melendi SE, Beratarrechea A, Gibbons L, Mills KT, Chen CS, Nejamis A, Gulayin P, Santero M, Chen J, Rubinstein A, He J, Irazola V. Cluster Randomized Trial for Hypertension Control: Effect on Lifestyles and Body Weight. Am J Prev Med. 2019 Oct;57(4):438-446. doi: 10.1016/j.amepre.2019.05.011. Epub 2019 Aug 29.

  • He J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, Chen CS, Gibbons L, Krousel-Wood M, Bazzano LA, Nejamis A, Gulayin P, Santero M, Augustovski F, Chen J, Rubinstein A; HCPIA Investigators. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial. JAMA. 2017 Sep 19;318(11):1016-1025. doi: 10.1001/jama.2017.11358.

MeSH Terms

Conditions

HypertensionMedication Adherence

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Jiang He, MD, PhD

    Tulane University Health Sciences Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair, Department of Epidemiology

Study Record Dates

First Submitted

April 13, 2013

First Posted

April 17, 2013

Study Start

June 1, 2013

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

July 17, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will share

Our study data sharing plan will comply with all NIH policies for data sharing. Sharing of data and scientific findings with the research and clinical communities will be executed through the centralized NIH data repository, publications in peer reviewed journals, and presentations at scientific meetings. Data sharing will be implemented in a timely manner. The study data, including data from baseline and follow-up visits, will be prepared for transmission to the NHLBI data repository beginning two years after the last subject completes the study visit. These data will be free of identifiers that allow identification of individual research participants either directly or through "deductive disclosure." In addition, we will offer through our public access website opportunities for outside investigators to collaborate with us using the complete study data and samples.

Shared Documents
STUDY PROTOCOL
Time Frame
Immediately after main paper published.

Locations